Radiation therapy firm Varian Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a new proton therapy system.
Marketed under the ProBeam brand, the system can deliver intensity-modulated proton therapy (IMPT) using pencil-beam scanning technology, according to the Palo Alto, CA-based vendor.
Varian said it has been selected as the preferred supplier for several proton therapy projects, including the Scripps Proton Therapy Center under construction in San Diego. In addition, the system has been selected for centers planned in Maryland, Italy, and other locations in the U.S. and Europe, the company said.
Related Reading
Varian wins German proton therapy contract, December 14, 2010
Varian brings Unique linac to Asia, December 13, 2010
Varian installs linac in Bulgaria, November 30, 2010
Varian to show new products at RSNA, November 23, 2010
Varian lands India order, November 2, 2010
Copyright © 2011 AuntMinnie.com
